About Reaction Biology
Reaction Biology is a company based in United States founded in 2001. The company has 77 employees as of December 31, 2021. Reaction Biology has completed 3 acquisitions, including Bioassay, Peptide Specialty Laboratories and ProQinase. Reaction Biology operates in a competitive market with competitors including Chroma Medicine, FOXO Technologies, ImmunoSCAPE, PhenoVista and Chronomics, among others.
- Headquarter United States
- Employees 77 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reaction Biology Europe Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Reaction Biology
Unlock access to complete
Funding Insights of Reaction Biology
Investors in Reaction Biology
Reaction Biology has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, National Cancer Institute and Cobepa.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cobepa is recognized as an independent investment company.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Research is conducted to advance translational science for health solutions.
|
Locked | Locked | Locked |
Investor details for Reaction Biology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Reaction Biology
Reaction Biology has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bioassay, Peptide Specialty Laboratories and ProQinase.
Investment portfolio details for Reaction Biology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biological assays for pharmaceutical and chemical products are specialized in.
|
Locked | Locked | 2002 | Locked | |
|
Contract research company for cancer drug discovery
|
Locked | Locked | 2001 | Locked | |
|
Medical research lab services in peptide specialties are provided.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Reaction Biology
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Reaction Biology
Detailed financials for Reaction Biology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reaction Biology Comparisons
Peer comparison for Reaction Biology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Reaction Biology
Reaction Biology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Chroma Medicine, FOXO Technologies, ImmunoSCAPE, PhenoVista and Chronomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Epigenetic editing platform is developed for genomic medicines.
|
|
| Locked | Locked | Locked |
Epigenetic biomarkers are discovered and developed via AI platforms.
|
|
| Locked | Locked | Locked |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| Locked | Locked | Locked |
A CRO that provides phenotypic assay development and screening services.
|
|
| Locked | Locked | Locked |
Proactive healthcare analysis is enabled by DNA-based epigenetic tests.
|
Detailed competitors of Reaction Biology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reaction Biology
Complete news archive for Reaction Biology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Reaction Biology
Reaction Biology was founded in 2001 and raised its 1st funding round 4 years after it was founded.
Reaction Biology is headquartered in United States.
As of Dec 31, 2021, the latest employee count at Reaction Biology is 77.
Reaction Biology was founded in 2001 in the United States as a contract research organization focused on biotechnology. In vitro enzyme activity assays are offered for high-throughput screening and profiling, with specialization in kinase, epigenetic regulatory enzymes, and protease activities. Services include compound library screening, cell-based assays, CYP and hERG profiling, custom assay development, and protein microarray applications, supporting drug discovery efforts across various therapeutic areas.
Reaction Biology's top competitors include Chroma Medicine, FOXO Technologies and ImmunoSCAPE.
Reaction Biology has made 3 acquisitions, including Bioassay, Peptide Specialty Laboratories, and ProQinase.
Reaction Biology has 5 investors. Key investors include HHS, National Cancer Institute, Cobepa, National Center for Advancing Translational Sciences, and National Institute of Dental and Craniofacial Research.